Top

Published in:

Open Access 01-08-2009 | Original Article

Volumetric and Functional Recovery of the Remnant Liver After Major Liver Resection with Prior Portal Vein Embolization

Recovery After PVE and Liver Resection

Authors: Jacomina W. van den Esschert, Wilmar de Graaf, Krijn P. van Lienden, Olivier R. Busch, Michal Heger, Otto M. van Delden, Dirk J. Gouma, Roelof J. Bennink, Johan S. Laméris, Thomas M. van Gulik

Published in: Journal of Gastrointestinal Surgery | Issue 8/2009

Abstract

Introduction

Portal vein embolization is an accepted method to increase the future remnant liver preoperatively. The aim of this study was to assess the effect of preoperative portal vein embolization on liver volume and function 3 months after major liver resection.

Materials and methods

This is a retrospective case-control study. Data were collected of patients who underwent portal vein embolization prior to (extended) right hemihepatectomy and of control patients who underwent the same type of resection without prior portal vein embolization. Liver volumes were measured by computed tomography volumetry before portal vein embolization, before liver resection, and 3 months after liver resection. Liver function was assessed by hepatobiliary scintigraphy before and 3 months after liver resection.

Results

Ten patients were included in the embolization group and 13 in the control group. Groups were comparable for gender, age, and number of patients with a compromised liver. The mean future remnant liver volume was 33.0 ± 8.0% prior to portal vein embolization in the embolization group and 45.6 ± 9.1% in the control group (p < 0.01). Prior to surgery, there were no significant differences in future remnant liver volume and function between the groups. Three months postoperatively, the mean remnant liver volume was 81.9 ± 8.9% of the initial total liver volume in the embolization group and 79.4 ± 11.0% in the control group (p > 0.05). Remnant liver function increased up to 88.1 ± 17.4% and 83.3 ± 14% respectively of the original total liver function (p > 0.05).

Conclusion

Preoperative portal vein embolization does not negatively influence postoperative liver regeneration assessed 3 months after major liver resection.

Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg. 2002;137(6):675–680. doi:10.1001/archsurg.137.6.675.CrossRefPubMed

Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg. 2000;232(5):665–672. doi:10.1097/00000658-200011000-00008.CrossRefPubMed

Azoulay D, Castaing D, Smail A, Adam R, Cailliez V, Laurent A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231(4):480–486. doi:10.1097/00000658-200004000-00005.CrossRefPubMed

Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57. doi:10.1097/SLA.0b013e31815f6e5b.CrossRefPubMed

Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000;127(5):512–519. doi:10.1067/msy.2000.105294.CrossRefPubMed

Heymsfield SB, Fulenwider T, Nordlinger B, Barlow R, Sones P, Kutner M. Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography. Ann Intern Med. 1979;90(2):185–187.PubMed

Bennink RJ, Dinant S, Erdogan D, Heijnen BH, Straatsburg IH, van Vliet AK, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med. 2004;45(6):965–971.PubMed

Kwon AH, Matsui Y, Ha-Kawa SK, Kamiyama Y. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol. 2001;96(2):541–546. doi:10.1111/j.1572-0241.2001.03556.x.CrossRefPubMed

Erdogan D, Heijnen BH, Bennink RJ, Kok M, Dinant S, Straatsburg IH, et al. Preoperative assessment of liver function: a comparison of 99mTc-mebrofenin scintigraphy with indocyanine green clearance test. Liver Int. 2004;24(2):117–123. doi:10.1111/j.1478-3231.2004.00901.x.CrossRefPubMed

10.

Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg. 2007;31(2):367–374. doi:10.1007/s00268-006-0526-2.CrossRefPubMed

11.

Sato Y, Koyama S, Tsukada K, Hatakeyama K. Acute portal hypertension reflecting shear stress as a trigger of liver regeneration following partial hepatectomy. Surg Today 1997;27(6):518–526. doi:10.1007/BF02385805.CrossRefPubMed

12.

Sato Y, Tsukada K, Hatakeyama K. Role of shear stress and immune responses in liver regeneration after a partial hepatectomy. Surg Today 1999;29(1):1–9. doi:10.1007/BF02482962.CrossRefPubMed

13.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi:10.1097/01.sla.0000133083.54934.ae.CrossRefPubMed

14.

Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26(5):1176–1181.PubMed

15.

Ekman M, Fjalling M, Friman S, Carlson S, Volkmann R. Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun. 1996;17(3):235–242. doi:10.1097/00006231-199603000-00011.CrossRefPubMed

16.

17.

Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237(2):208–217. doi:10.1097/00000658-200302000-00010.CrossRefPubMed

18.

Elias D, Ouellet JF, De BT, Lasser P, Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002;131(3):294–299. doi:10.1067/msy.2002.120234.CrossRefPubMed

19.

Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94(11):1386–1394. doi:10.1002/bjs.5836.CrossRefPubMed

20.

Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 2003;227(1):251–260. doi:10.1148/radiol.2271012010.CrossRefPubMed

21.

Takeuchi E, Nimura Y, Mizuno S, Nagino M, Shoji-Kawaguchi M, Izuta S, et al. Ligation of portal vein branch induces DNA polymerases alpha, delta, and epsilon in nonligated lobes. J Surg Res. 1996;65(1):15–24. doi:10.1006/jsre.1996.0337.CrossRefPubMed

22.

Fausto N. Liver regeneration. J Hepatol. 2000;32(Suppl 1):19–31. doi:10.1016/S0168-8278(00)80412-2.CrossRefPubMed

23.

24.

Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. The mystery of liver regeneration. Br J Surg. 2002;89(9):1089–1095. doi:10.1046/j.1365-2168.2002.02166.x.CrossRefPubMed

25.

Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5(10):836–847. doi:10.1038/nrm1489.CrossRefPubMed

26.

Rokicki M, Rokicki W. Liver regeneration in rats after complete and partial occlusion of the portal blood influx. Res Exp Med (Berl). 1993;193(5):305–313. doi:10.1007/BF02576238.CrossRef

27.

Hata Y, Yoshikawa Y, Une Y, Sasaki F, Nakajima Y, Takahashi H, et al. Liver regeneration following portacaval shunt in rats: 3′,5′-cyclic AMP changes in plasma and liver tissue. Res Exp Med (Berl). 1992;192(2):131–136. doi:10.1007/BF02576267.CrossRef

28.

Vetelainen R, Dinant S, van Vliet A, van Gulik TM. Portal vein ligation is as effective as sequential portal vein and hepatic artery ligation in inducing contralateral liver hypertrophy in a rat model. J Vasc Interv Radiol. 2006;17(7):1181–1188.PubMedCrossRef

Title: Volumetric and Functional Recovery of the Remnant Liver After Major Liver Resection with Prior Portal Vein Embolization
Recovery After PVE and Liver Resection
Authors: Jacomina W. van den Esschert
Wilmar de Graaf
Krijn P. van Lienden
Olivier R. Busch
Michal Heger
Otto M. van Delden
Dirk J. Gouma
Roelof J. Bennink
Johan S. Laméris
Thomas M. van Gulik
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 8/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-009-0929-0

At a glance: The STEP trials

Springer Medicine

Volumetric and Functional Recovery of the Remnant Liver After Major Liver Resection with Prior Portal Vein Embolization

Recovery After PVE and Liver Resection

Abstract

Introduction

Materials and methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2009

Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux Symptoms

Gemcitabine-Based Adjuvant Chemotherapy Improves Survival After Aggressive Surgery for Hilar Cholangiocarcinoma

Assessment of “Gene–Environment” Interaction in Cases of Familial and Sporadic Pancreatic Cancer

Molecular Analysis of PIK3CA, BRAF, and RAS Oncogenes in Periampullary and Ampullary Adenomas and Carcinomas

Abdominal Computed Tomography for Diagnosing Postoperative Lower Gastrointestinal Tract Leaks

Comparative Analysis of Outcomes in Living and Deceased Donor Liver Transplants for Primary Sclerosing Cholangitis